• Price (USD)38.74
  • Today's Change0.00 / 0.00%
  • Shares traded73.00
  • 1 Year change-16.73%
  • Beta--
Data delayed at least 15 minutes, as of Jan 31 2023.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Spectris plc is a United Kingdom-based company, which provides customers with expert insight through its advanced instruments and test equipment, augmented through its software and services. The Company's segments include Malvern Panalytical, HBK, and Industrial Solutions division (ISD). The Malvern Panalytical segment provides products and services that enable customers to determine structure, composition, quantity and quality of particles and materials during their research and product development processes, when assessing materials before production, or during the manufacturing process. The operating companies in this segment are Malvern Panalytical and Concept Life Sciences. The HBK segment supplies test, measurement and analysis equipment, software and services for product design optimization, and manufacturing control. The operating companies in this segment are Hottinger, Bruel & Kjaer and VI-grade. The ISD segment comprises a portfolio of niche businesses.

  • Revenue in GBP (TTM)1.20bn
  • Net income in GBP188.40m
  • Incorporated1986
  • Employees7.79k
  • Location
    Spectris PLC5th Floor Melbourne House44-46 AldwychLONDON WC2B 4LLUnited KingdomGBR
  • Websitehttp://www.spectris.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SXS:LSE since
Dytran Instruments IncDeal completed10 May 202210 May 2022Deal completed15.62%82.00m
Oxford Instruments PLCDeal withdrawn28 Feb 202228 Feb 2022Deal withdrawn6.58%2.40bn
Data delayed at least 20 minutes, as of Feb 03 2023 16:09 GMT.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.